[
  {
    "objectID": "quarto/index.html",
    "href": "quarto/index.html",
    "title": "Clinical Outcomes of MS in CVD",
    "section": "",
    "text": "Reference Papers:\n\nSidhu et al. 2022\n\nStudy Objective: Examine the impact of MS on in-hospital mortality and length of stay among inpatient admissions with a principal diagnosis of CVD.\nData Source: Cross-sectional analysis of the National Inpatient Sample (NIS) from 2018 to 2020.\nPatient Selection: Included all inpatient admissions with a principal diagnosis of Stroke.\nCVD + MS Categories:\n\nCVD with MS\nCVD without MS\n\nPrimary Outcomes:\n\nIn-hospital all-cause mortality\nTotal hospital length of stay (days)\nTotal charge, inflation adjusted to 2020 ($)\n\nStatistical Analysis: Multiple logistic and linear regression to determine the independent association of atrial fibrillation with in-hospital mortality, stroke mortality, length of stay and total charges (inflation adjusted), respectively, adjusted for:\n\nDemographics: Age, sex, race, residential income, insurance, hospital region, hospital bedsize, hospital location, and teaching status.\nMedical History: Hypertension, diabetes mellitus, hyperlipidemia, coronary artery disease, peripheral vascular disease, heart failure, chronic kidney disease, chronic obstructive pulmonary disease, dementia, liver disease, obstructive sleep apnea, anemia, obesity, alochol use disorder, prior stroke, prior cardiac surgery, presence of pacemaker/defibrillator, tobacco use disorder, use of tissue plasminogen activator and use of thrombectomy.\nComorbidities: Charlson comorbidity index.\n\nSoftware: All analyses were performed using R Version 4.4.1 (R Foundation for Statistical Computing, Vienna, Austria)"
  },
  {
    "objectID": "quarto/index.html#preamble",
    "href": "quarto/index.html#preamble",
    "title": "Clinical Outcomes of MS in CVD",
    "section": "",
    "text": "Reference Papers:\n\nSidhu et al. 2022\n\nStudy Objective: Examine the impact of MS on in-hospital mortality and length of stay among inpatient admissions with a principal diagnosis of CVD.\nData Source: Cross-sectional analysis of the National Inpatient Sample (NIS) from 2018 to 2020.\nPatient Selection: Included all inpatient admissions with a principal diagnosis of Stroke.\nCVD + MS Categories:\n\nCVD with MS\nCVD without MS\n\nPrimary Outcomes:\n\nIn-hospital all-cause mortality\nTotal hospital length of stay (days)\nTotal charge, inflation adjusted to 2020 ($)\n\nStatistical Analysis: Multiple logistic and linear regression to determine the independent association of atrial fibrillation with in-hospital mortality, stroke mortality, length of stay and total charges (inflation adjusted), respectively, adjusted for:\n\nDemographics: Age, sex, race, residential income, insurance, hospital region, hospital bedsize, hospital location, and teaching status.\nMedical History: Hypertension, diabetes mellitus, hyperlipidemia, coronary artery disease, peripheral vascular disease, heart failure, chronic kidney disease, chronic obstructive pulmonary disease, dementia, liver disease, obstructive sleep apnea, anemia, obesity, alochol use disorder, prior stroke, prior cardiac surgery, presence of pacemaker/defibrillator, tobacco use disorder, use of tissue plasminogen activator and use of thrombectomy.\nComorbidities: Charlson comorbidity index.\n\nSoftware: All analyses were performed using R Version 4.4.1 (R Foundation for Statistical Computing, Vienna, Austria)"
  },
  {
    "objectID": "quarto/index.html#baseline-table",
    "href": "quarto/index.html#baseline-table",
    "title": "Clinical Outcomes of MS in CVD",
    "section": "Baseline Table:",
    "text": "Baseline Table:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOverall N = 2,697,2851\nCVD with MS N = 652,5151\nCVD without MS N = 2,044,7701\np-value2\n\n\n\n\nAge, y\n69 (14)\n73 (11)\n68 (15)\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n&lt;0.001\n\n\n    Female\n1,316,685 (49)\n257,160 (39)\n1,059,525 (52)\n\n\n\n\n    Male\n1,380,475 (51)\n395,330 (61)\n985,145 (48)\n\n\n\n\nRace\n\n\n\n\n\n\n&lt;0.001\n\n\n    White\n1,786,970 (68)\n480,350 (76)\n1,306,620 (66)\n\n\n\n\n    Asian or Pacific Islander\n86,710 (3.3)\n14,890 (2.3)\n71,820 (3.6)\n\n\n\n\n    Black\n434,350 (17)\n79,275 (12)\n355,075 (18)\n\n\n\n\n    Hispanic\n228,465 (8.7)\n43,925 (6.9)\n184,540 (9.3)\n\n\n\n\n    Native American\n13,260 (0.5)\n2,710 (0.4)\n10,550 (0.5)\n\n\n\n\n    Other\n72,975 (2.8)\n14,780 (2.3)\n58,195 (2.9)\n\n\n\n\nCharlson comorbidity index\n3.44 (2.08)\n4.24 (2.18)\n3.19 (1.98)\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n&lt;0.001\n\n\n    $1 - $51,999\n801,675 (30)\n194,780 (30)\n606,895 (30)\n\n\n\n\n    $52,000 - $65,999\n712,045 (27)\n180,040 (28)\n532,005 (26)\n\n\n\n\n    $66,000 - $87,999\n632,865 (24)\n152,690 (24)\n480,175 (24)\n\n\n\n\n    $88,000 or more\n507,880 (19)\n115,580 (18)\n392,300 (20)\n\n\n\n\nExpected primary payer\n\n\n\n\n\n\n&lt;0.001\n\n\n    Private\n645,795 (24)\n98,830 (15)\n546,965 (27)\n\n\n\n\n    Medicaid\n264,665 (9.8)\n40,030 (6.1)\n224,635 (11)\n\n\n\n\n    Medicare\n1,719,965 (64)\n499,525 (77)\n1,220,440 (60)\n\n\n\n\n    Other\n63,210 (2.3)\n13,405 (2.1)\n49,805 (2.4)\n\n\n\n\nHospital region\n\n\n\n\n\n\n&lt;0.001\n\n\n    Midwest\n593,715 (22)\n160,090 (25)\n433,625 (21)\n\n\n\n\n    Northeast\n461,440 (17)\n110,115 (17)\n351,325 (17)\n\n\n\n\n    South\n1,127,510 (42)\n280,790 (43)\n846,720 (41)\n\n\n\n\n    West\n514,620 (19)\n101,520 (16)\n413,100 (20)\n\n\n\n\nHospital bedsize\n\n\n\n\n\n\n&lt;0.001\n\n\n    Large\n1,493,355 (55)\n355,970 (55)\n1,137,385 (56)\n\n\n\n\n    Medium\n750,485 (28)\n184,780 (28)\n565,705 (28)\n\n\n\n\n    Small\n453,445 (17)\n111,765 (17)\n341,680 (17)\n\n\n\n\nHospital location and teaching status\n\n\n\n\n\n\n&lt;0.001\n\n\n    Rural\n169,170 (6.3)\n44,060 (6.8)\n125,110 (6.1)\n\n\n\n\n    Urban, non-teaching\n442,825 (16)\n112,145 (17)\n330,680 (16)\n\n\n\n\n    Urban, teaching\n2,085,290 (77)\n496,310 (76)\n1,588,980 (78)\n\n\n\n\nHypertension\n2,261,495 (84)\n601,915 (92)\n1,659,580 (81)\n&lt;0.001\n\n\nDiabetes mellitus\n1,001,335 (37)\n315,125 (48)\n686,210 (34)\n&lt;0.001\n\n\nPeripheral vascular disease\n261,900 (9.7)\n113,480 (17)\n148,420 (7.3)\n&lt;0.001\n\n\nHeart failure\n464,830 (17)\n215,165 (33)\n249,665 (12)\n&lt;0.001\n\n\nCOPD\n453,720 (17)\n154,715 (24)\n299,005 (15)\n&lt;0.001\n\n\nChronic kidney disease\n493,095 (18)\n176,790 (27)\n316,305 (15)\n&lt;0.001\n\n\n\n1 Mean (SD); n (%)\n\n\n2 Design-based KruskalWallis test; Pearson’s X^2: Rao & Scott adjustment"
  },
  {
    "objectID": "quarto/index.html#outcomes-table",
    "href": "quarto/index.html#outcomes-table",
    "title": "Clinical Outcomes of MS in CVD",
    "section": "Outcomes Table:",
    "text": "Outcomes Table:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOverall N = 2,697,2851\nCVD with MS N = 652,5151\nCVD without MS N = 2,044,7701\np-value2\n\n\n\n\nDied during hospitalization\n137,625 (5.1)\n29,390 (4.5)\n108,235 (5.3)\n&lt;0.001\n\n\nLength of stay (days)\n6 (9)\n6 (7)\n6 (9)\n&lt;0.001\n\n\nInflation-adjusted total charge ($)\n84,342 (125,922)\n74,256 (91,597)\n87,559 (134,891)\n&lt;0.001\n\n\n\n1 n (%); Mean (SD)\n\n\n2 Pearson’s X^2: Rao & Scott adjustment; Design-based KruskalWallis test"
  },
  {
    "objectID": "quarto/index.html#multivariable-logistic-regression",
    "href": "quarto/index.html#multivariable-logistic-regression",
    "title": "Clinical Outcomes of MS in CVD",
    "section": "Multivariable Logistic Regression:",
    "text": "Multivariable Logistic Regression:\n\nAll-Cause Mortality:\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR (95% CI)1\np-value\n\n\n\n\nCVD categories\n\n\n\n\n\n\n    CVD with MS\n—\n\n\n\n\n    CVD without MS\n1.28 (1.24 to 1.32)\n&lt;0.001\n\n\nAge, y\n1.02 (1.02 to 1.02)\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n    Female\n—\n\n\n\n\n    Male\n0.99 (0.96 to 1.01)\n0.34\n\n\nRace\n\n\n\n\n\n\n    White\n—\n\n\n\n\n    Asian or Pacific Islander\n1.33 (1.25 to 1.43)\n&lt;0.001\n\n\n    Black\n0.92 (0.88 to 0.96)\n&lt;0.001\n\n\n    Hispanic\n1.07 (1.01 to 1.13)\n0.017\n\n\n    Native American\n1.01 (0.83 to 1.23)\n0.90\n\n\n    Other\n1.33 (1.23 to 1.44)\n&lt;0.001\n\n\nCharlson comorbidity index\n1.14 (1.13 to 1.14)\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n    $1 - $51,999\n—\n\n\n\n\n    $52,000 - $65,999\n0.92 (0.89 to 0.96)\n&lt;0.001\n\n\n    $66,000 - $87,999\n0.87 (0.83 to 0.90)\n&lt;0.001\n\n\n    $88,000 or more\n0.86 (0.82 to 0.90)\n&lt;0.001\n\n\nExpected primary payer\n\n\n\n\n\n\n    Private\n—\n\n\n\n\n    Medicaid\n1.10 (1.04 to 1.16)\n&lt;0.001\n\n\n    Medicare\n0.85 (0.81 to 0.89)\n&lt;0.001\n\n\n    Other\n1.68 (1.51 to 1.86)\n&lt;0.001\n\n\nHospital region\n\n\n\n\n\n\n    Midwest\n—\n\n\n\n\n    Northeast\n1.18 (1.11 to 1.26)\n&lt;0.001\n\n\n    South\n1.08 (1.03 to 1.14)\n0.002\n\n\n    West\n1.26 (1.19 to 1.34)\n&lt;0.001\n\n\nHospital bedsize\n\n\n\n\n\n\n    Large\n—\n\n\n\n\n    Medium\n0.78 (0.74 to 0.81)\n&lt;0.001\n\n\n    Small\n0.61 (0.57 to 0.65)\n&lt;0.001\n\n\nHospital location and teaching status\n\n\n\n\n\n\n    Rural\n—\n\n\n\n\n    Urban, non-teaching\n0.96 (0.88 to 1.04)\n0.29\n\n\n    Urban, teaching\n1.45 (1.35 to 1.56)\n&lt;0.001\n\n\nHypertension\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n0.59 (0.57 to 0.61)\n&lt;0.001\n\n\nDiabetes mellitus\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n0.66 (0.64 to 0.68)\n&lt;0.001\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n0.66 (0.63 to 0.69)\n&lt;0.001\n\n\nHeart failure\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n1.35 (1.31 to 1.40)\n&lt;0.001\n\n\nChronic kidney disease\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n0.87 (0.83 to 0.90)\n&lt;0.001\n\n\n\n1 OR = Odds Ratio, CI = Confidence Interval"
  },
  {
    "objectID": "quarto/index.html#multivariable-linear-regression",
    "href": "quarto/index.html#multivariable-linear-regression",
    "title": "Clinical Outcomes of MS in CVD",
    "section": "Multivariable Linear Regression:",
    "text": "Multivariable Linear Regression:\n\nLength of Stay:\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nexp(Beta) (95% CI)1\np-value\n\n\n\n\nCVD categories\n\n\n\n\n\n\n    CVD with MS\n—\n\n\n\n\n    CVD without MS\n2.24 (2.12 to 2.37)\n&lt;0.001\n\n\nAge, y\n0.98 (0.98 to 0.98)\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n    Female\n—\n\n\n\n\n    Male\n1.23 (1.17 to 1.29)\n&lt;0.001\n\n\nRace\n\n\n\n\n\n\n    White\n—\n\n\n\n\n    Asian or Pacific Islander\n4.05 (3.32 to 4.94)\n&lt;0.001\n\n\n    Black\n3.77 (3.40 to 4.17)\n&lt;0.001\n\n\n    Hispanic\n2.25 (1.98 to 2.55)\n&lt;0.001\n\n\n    Native American\n1.32 (0.93 to 1.89)\n0.12\n\n\n    Other\n4.46 (3.60 to 5.52)\n&lt;0.001\n\n\nCharlson comorbidity index\n1.22 (1.19 to 1.25)\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n    $1 - $51,999\n—\n\n\n\n\n    $52,000 - $65,999\n0.95 (0.88 to 1.02)\n0.17\n\n\n    $66,000 - $87,999\n0.91 (0.83 to 0.99)\n0.037\n\n\n    $88,000 or more\n0.95 (0.84 to 1.06)\n0.36\n\n\nExpected primary payer\n\n\n\n\n\n\n    Private\n—\n\n\n\n\n    Medicaid\n9.31 (7.95 to 10.9)\n&lt;0.001\n\n\n    Medicare\n1.01 (0.94 to 1.09)\n0.79\n\n\n    Other\n0.83 (0.70 to 0.99)\n0.040\n\n\nHospital region\n\n\n\n\n\n\n    Midwest\n—\n\n\n\n\n    Northeast\n1.52 (1.27 to 1.82)\n&lt;0.001\n\n\n    South\n1.32 (1.16 to 1.50)\n&lt;0.001\n\n\n    West\n1.08 (0.92 to 1.26)\n0.34\n\n\nHospital bedsize\n\n\n\n\n\n\n    Large\n—\n\n\n\n\n    Medium\n0.48 (0.42 to 0.54)\n&lt;0.001\n\n\n    Small\n0.37 (0.31 to 0.43)\n&lt;0.001\n\n\nHospital location and teaching status\n\n\n\n\n\n\n    Rural\n—\n\n\n\n\n    Urban, non-teaching\n0.94 (0.77 to 1.14)\n0.51\n\n\n    Urban, teaching\n2.20 (1.86 to 2.59)\n&lt;0.001\n\n\nHypertension\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n0.95 (0.86 to 1.05)\n0.34\n\n\nDiabetes mellitus\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n0.75 (0.70 to 0.80)\n&lt;0.001\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n0.49 (0.45 to 0.53)\n&lt;0.001\n\n\nHeart failure\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n3.77 (3.49 to 4.09)\n&lt;0.001\n\n\nChronic kidney disease\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n1.13 (1.04 to 1.23)\n0.004\n\n\n\n1 CI = Confidence Interval\n\n\n\n\n\n\n\n\n\n\nInflation Adjusted Total Charge:\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nBeta (95% CI)1\np-value\n\n\n\n\nCVD categories\n\n\n\n\n\n\n    CVD with MS\n—\n\n\n\n\n    CVD without MS\n5,905 (5,124 to 6,687)\n&lt;0.001\n\n\nAge, y\n-964 (-1,017 to -910)\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n    Female\n—\n\n\n\n\n    Male\n-1,525 (-2,260 to -790)\n&lt;0.001\n\n\nRace\n\n\n\n\n\n\n    White\n—\n\n\n\n\n    Asian or Pacific Islander\n22,512 (17,850 to 27,174)\n&lt;0.001\n\n\n    Black\n7,686 (5,687 to 9,684)\n&lt;0.001\n\n\n    Hispanic\n27,404 (23,813 to 30,994)\n&lt;0.001\n\n\n    Native American\n-10,291 (-15,544 to -5,039)\n&lt;0.001\n\n\n    Other\n32,251 (27,641 to 36,861)\n&lt;0.001\n\n\nCharlson comorbidity index\n4,947 (4,651 to 5,242)\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n    $1 - $51,999\n—\n\n\n\n\n    $52,000 - $65,999\n429 (-1,060 to 1,918)\n0.57\n\n\n    $66,000 - $87,999\n-13 (-1,920 to 1,894)\n0.99\n\n\n    $88,000 or more\n6,424 (3,580 to 9,268)\n&lt;0.001\n\n\nExpected primary payer\n\n\n\n\n\n\n    Private\n—\n\n\n\n\n    Medicaid\n15,751 (13,448 to 18,054)\n&lt;0.001\n\n\n    Medicare\n1,378 (74 to 2,681)\n0.038\n\n\n    Other\n105 (-3,116 to 3,326)\n0.95\n\n\nHospital region\n\n\n\n\n\n\n    Midwest\n—\n\n\n\n\n    Northeast\n22,693 (17,962 to 27,423)\n&lt;0.001\n\n\n    South\n15,449 (12,809 to 18,089)\n&lt;0.001\n\n\n    West\n41,476 (37,024 to 45,928)\n&lt;0.001\n\n\nHospital bedsize\n\n\n\n\n\n\n    Large\n—\n\n\n\n\n    Medium\n-15,494 (-18,778 to -12,210)\n&lt;0.001\n\n\n    Small\n-26,189 (-29,678 to -22,701)\n&lt;0.001\n\n\nHospital location and teaching status\n\n\n\n\n\n\n    Rural\n—\n\n\n\n\n    Urban, non-teaching\n26,978 (23,795 to 30,160)\n&lt;0.001\n\n\n    Urban, teaching\n43,908 (41,741 to 46,075)\n&lt;0.001\n\n\nHypertension\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n-8,319 (-9,945 to -6,693)\n&lt;0.001\n\n\nDiabetes mellitus\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n-13,708 (-14,702 to -12,714)\n&lt;0.001\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n-7,685 (-8,860 to -6,511)\n&lt;0.001\n\n\nHeart failure\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n11,555 (10,410 to 12,700)\n&lt;0.001\n\n\nChronic kidney disease\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n-9,073 (-10,268 to -7,878)\n&lt;0.001\n\n\n\n1 CI = Confidence Interval"
  }
]